Fabrice Marger

Title: Fabrice Marger: Innovator in Analgesic Research

Introduction

Fabrice Marger is a notable inventor based in Saint Jean de Vedas, France. He has made significant contributions to the field of analgesic research, particularly through his innovative work on calcium channel antagonists.

Latest Patents

Fabrice Marger holds a patent for the "Identification of novel antagonist toxins of T-type calcium channel for analgesic purposes." This patent includes a peptide with the sequence YCQKFLWTCDSERPCCEGLVCRLWCKIN (SEQ ID NO 1) or a derivative thereof. It also encompasses nucleic acids coding for the peptide and outlines the use of this peptide as an antagonist and/or reverse agonist of T-type calcium channels. Furthermore, the patent details the application of this peptide in preparing a drug, specifically an analgesic.

Career Highlights

Throughout his career, Fabrice Marger has worked with esteemed institutions such as Université de Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. His research has focused on the development of novel therapeutic agents aimed at pain relief.

Collaborations

Fabrice has collaborated with notable colleagues, including Joël Nargeot and Emmanuel Bourinet, contributing to advancements in his field.

Conclusion

Fabrice Marger is a distinguished inventor whose work in analgesic research has the potential to impact pain management significantly. His innovative approaches and collaborations highlight his commitment to advancing medical science.